Table 1.
TIME | CONTROL GROUP | INTERVENTION GROUP | WHO DOES IT |
---|---|---|---|
Admission | Review of inclusion and exclusion criteria Informed consent Randomisation BASELINE VARIABLES |
Case manager | |
ROUTINE MEDICAL MONITORING (will vary across centres) |
Educational session Knowledge of disease Drugs Comorbidity Follow-up information Plan for discharge Questionnaires on self-care and disease knowledge for patient and caregiver |
||
2 weeks | Telephone contact Symptoms-signs Compliance Next appointment |
Case manager | |
1 month | Consultation with case manager Educational reinforcement Drugs-Compliance Comorbidity Follow-up |
Case manager | |
2 months | Consultation with case manager Similar to above | Case manager | |
3 months | Consultation with case manager Similar to above | Case manager | |
6 months | Consultation with physician | Physician | |
Consultation with case manager Similar to above |
Case manager | ||
REGISTRY OF VARIABLES | Research team | ||
8 months | Consultation with case manager Similar to above | Case manager | |
12 months | Consultation with physician | Physician | |
Consultation with case manager Similar to above |
Case manager | ||
REGISTRY OF VARIABLES | Research team |